Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › Pimco's Stracke Says AI-Related Financing in Early Innings
Business & Finance

Pimco's Stracke Says AI-Related Financing in Early Innings

Bloomberg Technology Monday 03 August 2026, 16:11 UTC 1 min read
Key Points

Aug 3rd, 2026 Pimco's Stracke Says AI-Related Financing in Early Innings Pimco President Christian Stracke says the financing of digital infrastructure is only in the early innings. Speaking on "Bloomberg Open Interest," Stracke also discusses the risks in the lending market, the private credit "confidence gap" and where he sees financing opportunities in the current environment.

Aug 3rd, 2026 Pimco's Stracke Says AI-Related Financing in Early Innings Pimco President Christian Stracke says the financing of digital infrastructure is only in the early innings. Speaking on "Bloomberg Open Interest," Stracke also discusses the risks in the lending market, the private credit "confidence gap" and where he sees financing opportunities in the current environment.
Pimco (ORG) AI-Related Financing (ORG) Christian Stracke (PERSON)
Originally published by Bloomberg Technology Read original →

Related Stories

If I buy a house for $1 million in cash at 70, will I run out of money by 90?

MarketWatch 11m ago

Apple launches legal challenge against UK government demand to access data

The Guardian Business 19m ago

Citadel Securities’ Shah Says Markets Questioning Warsh’s Plans

Citadel Securities’ Shah Says Markets Questioning Warsh’s Plans Federal Reserve Chairman Kevin Warsh is creating fresh uncertainty for investors by pledging to rein in inflation without explaining how he intends to do so, according to Citadel Securities. While Warsh has repeatedly said the central bank needs to tame consumer-price increases that have exceeded its target for five straight years, the Fed again left interest rates unchanged last week even as three policymakers favored an...

Bloomberg Markets 30m ago

AstraZeneca should stick to its winning formula. It doesn’t need a $400bn US mega-merger

The Anglo-Swedish drugmaker’s flirtation with a grand combo with US group Bristol Myers Squibb is baffling• AstraZeneca shares fall 8.9% over merger talks with US cancer drug firmSir Pascal Soriot, chief executive of AstraZeneca, starts with huge credit in the bank, obviously. His long tenure has been a triumph, starting with the against-the-odds victory over Pfizer’s charmless accountants in 2014.The $39bn (£29bn) purchase of Alexion in 2021 looked a little over-priced at the time, but you...

The Guardian Business 32m ago